Showing 1,741 - 1,760 results of 18,072 for search 'significant ((((((gap decrease) OR (greatest decrease))) OR (we decrease))) OR (a decrease))', query time: 0.55s Refine Results
  1. 1741
  2. 1742
  3. 1743
  4. 1744
  5. 1745

    ANOM analysis of evaluated criteria K1–K5. by Roman Vavrek (13200141)

    Published 2024
    “…Based on the performed analyses, we can see that significant differences result from their reduction. …”
  6. 1746

    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice by Chenglu Peng (19935965)

    Published 2024
    “…This, in turn, triggered the TFEB signaling pathway and thus upregulated the lysosomal exocytosis level, leading to lysosomal enzymes to be released to the intestinal lumen. As a result, a decreased number of intestinal goblet cells, diminished tight junction protein expression, and imbalanced intestinal flora in mice were observed. …”
  7. 1747

    Exclusion and enrollment summary from NHANES. by Lu Han (151620)

    Published 2025
    “…Individuals under 30 showed no significant differences. A unit increase below 9.30 in Log2-PMR reduced HCV risk by 0.60-fold. …”
  8. 1748
  9. 1749
  10. 1750
  11. 1751
  12. 1752
  13. 1753
  14. 1754

    Reagent list. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  15. 1755

    Data for figures. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  16. 1756
  17. 1757
  18. 1758

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
  19. 1759
  20. 1760

    S1 Raw data - by Muhammad Naeem Sattar (19828497)

    Published 2024
    “…The larval duration was also decreased significantly in the larvae treated with all the dsRNA treatments. …”